Discovery and Basic Research - Pharmacology

(W0930-05-27) Pharmacodynamic Assessments of Paclitaxel in Combination with Calcipotriol in Pancreatic Ductal Adenocarcinoma (PDAC)

(T0930-05-28) Antipsychotic Agent Pimavanserin, a Potential Therapy for Glioblastoma

(W0930-05-28) LC-MS/MS Method Development and Validation for Evaluation of Brain Pharmacokinetic Parameters of Metformin after an Intravenous Bolus Administration: Application in Ischemic Stroke

(T0930-05-29) Effect of Propofol on the In Vitro Model of the Blood-Brain Barrier Based on Induced Pluripotent Stem Cell-Derived Human Brain Microvascular Endothelial Cells

(M0930-05-29) Piperlongumine Reverses EGFR Resistance as an Adjuvant Treatment in Lung Cancer Cells

(T0930-10-58) Hazard Analysis of Amorphous Silica Nanoparticle via Acquired Immune System

(W0930-10-58) Modulating Host Response to Sepsis via Pure Anti-inflammatory Heparin-Like Compounds

(M0930-10-58) Modulation of the Activity of Histone Lysine Methylation Writers and Erasers in Leukemia Cells by a Curcumin Analog

(M0930-10-59) Implementing of Next-Generation Sequencing-Based Approach for Pharmacogenomics Profiling and Exploring Its Potential Clinical Utilities

(T0930-10-59) Interventional Treatment with an mPGES-1 Inhibitor Halts Further Growth of Abdominal Aortic Aneurysms in the Ang-II Mouse Model

(W0930-10-59) Intracellular Accumulation and Washout Kinetics of Aminoglycosides (AGS) in Multidrug-Resistant (MDR) Klebsiella pneumoniae

(W1030-05-28) Effects of B4GALNT1 Expression on Metastatic Phenotype and Response to Treatment in Osteosarcoma Cell Lines

(W1030-05-29) Cinnamaldehyde DNA Adducts are Mutagenic and Block Replication

(M1030-05-29) Computational Toxicity Prediction for Compounds of Unknown Toxicity using Bulk RNA-Seq: A Case of Liver Toxicity

(T1030-05-29) Radioprotective Effects of a Standardized Tocotrienol Rich Extract from Annato Seeds (Bixa orellana L.)

(M1030-05-30) Analysis of Amino Acid Content in Commercially Available Supplements

(W1030-10-58) Characterization of Selective CYP46A1 Inhibitors and Activators Across Compound Library Using a High-Throughput Screening Platform

(W1030-10-59) Replication Block and Mutagenicity of Aminofluorene-Guanine Adduct Inepigenetically Modified Sequence Contexts

(W1130-05-28) Polymeric Delivery with Dual Drug Payloads for Hepatocellular Carcinoma (HCC) Therapy

(T1130-05-28) The Inhibition of Proteolytic and ATPase Activities of the Proteasome by the BTK Inhibitor CGI-1746

(M1130-05-29) Development of Novel Macropinocytosis Inducers to Enhance Cellular Uptake of Small and Large Molecules

(T1130-05-29) Endogenous Blood-Brain Barrier Transporters are Critical Determinants of Neuroprotective Drug Efficacy in Ischemic Stroke

(W1130-05-29) Inactivation of Integrated Stress Response Pathway Sensitizes Triple-Negative Breast Cancer Cells to Proteasome Inhibitors

(M1130-10-58) Drug Repurposing: A Therapeutic Approach to Modulate Immune Microenvironment in Pancreatic Cancer

(T1130-10-58) Predictability of In Vitro Hepatocyte Induction Data in a PBPK Framework for CYP3A4 Induction Risk Assessment

(T1130-10-59) Simultaneously Inactivating Three or all Four Penicillin-Binding Proteins (PBPs) among PBP1a, 1b, 2 and 3 Synergistically Kills Acinetobacter baumannii (AB)

(M1130-10-59) Systems Biology Modeling of the Insulin Signaling Network in the Blood-Brain Barrier Endothelium Predicts Cerebrovascular Inflammation in Alzheimer’s disease

(T1230-05-29) Curcumin as a Repurposed Adjuvant to Overcome Antibiotic Resistance in Pseudomonas aeruginosa, Burkholderia cenocepacia and Burkholderia multivorans Clinical Isolates

(T1230-10-59) Discovery of Anti-LAG-3 Peptides for Cancer Immunotherapy

(M1230-10-59) Identifying Novel Synthetic Lethal Drug Targets to Overcome Chemotherapy Resistance in Triple Negative Breast Cancer by Genome-Wide CRISPR/Cas9 Screen Paralleled with Transcriptome RNAseq

(T1330-05-28) Prenatal E-Cigarette Use Disrupts Postnatal Blood-Brain Barrier (BBB) Integrity and Worsens Ischemic Stroke Outcomes- Implications on Brain Drug Delivery

(M1330-05-29) A Listeria-Based Vaccine Targeting Interferon-Stimulated Gene 15 for Renal Cell Carcinoma

(T1330-05-29) A Promising Protein Therapeutic Candidate for the Treatment of Cocaine Toxicity in the Presence of Alcohol

(T1330-10-58) Design and Development of Protease-Activated Chemically Self-Assembled Nanorings (Pro-CSANs) for Cancer Immunotherapy

(M1330-10-58) L-carnitine Challenge Test as an Indicator of Sex-Related Predisposition for Adverse Drug Reactions

(M1330-10-59) Determining the Efficacy and Toxicity Profile of Potential Oral Therapeutics Against SARS-CoV-2 in Mice

(T1330-10-59) Statins Constrict Resistance-Size Cerebral Arteries by Stimulating L-type Ca²⁺ Channels

(M1430-05-29) KY-054, a Novel 4-aryl Chromene Derivative, Enhances Osteoblast Differentiation of Mesenchymal Stem Cells and Shows Osteogenetic Effects in Ovariectomized Rats

(T1430-10-59) Development of a Broadly Active Influenza Intranasal Vaccine Adjuvanted with Self-Assembled Particles Comprised of Mastoparan-7 and CpG

(T1530-05-29) Nervonic Acid - A Potential Therapeutic Targeting Mitochondrial Dysfunction and Cellular Oxidative Stress

(M1530-10-59) Discovery of OJT009 as a Novel Inhibitor of Severe Acute Respiratory Syndrome Coronavirus 2